Targeting gastrointestinal stromal tumor with 68Ga-labeled peptides: an in vitro study on gastrointestinal stromal tumor-cell lines

The gastrointestinal stromal tumor (GIST) is a rare disease with limited therapeutic options when resistance to tyrosine kinase inhibitor (TKI) treatment occurs. The authors investigated binding of various 68Ga-labeled peptides, targeting receptors reported to be overexpressed in GIST, in different...

Full description

Saved in:
Bibliographic Details
Main Authors: Paulmichl, Achim (Author) , Wängler, Björn (Author)
Format: Article (Journal)
Language:English
Published: 1 Oct 2016
In: Cancer biotherapy and radiopharmaceuticals
Year: 2016, Volume: 31, Issue: 8, Pages: 302-310
ISSN:1557-8852
DOI:10.1089/cbr.2016.2092
Online Access:Verlag, Volltext: https://doi.org/10.1089/cbr.2016.2092
Verlag, Volltext: https://www.liebertpub.com/doi/10.1089/cbr.2016.2092
Get full text
Author Notes:Achim Paulmichl, Dominik Summer, Claudia Manzl, Christine Rangger, Francesca Orlandi, Sabrina Niedermoser, Takahiro Taguchi, Björn Wängler, Clemens Decristoforo

MARC

LEADER 00000caa a2200000 c 4500
001 1669214087
003 DE-627
005 20230428192243.0
007 cr uuu---uuuuu
008 190716s2016 xx |||||o 00| ||eng c
024 7 |a 10.1089/cbr.2016.2092  |2 doi 
035 |a (DE-627)1669214087 
035 |a (DE-599)KXP1669214087 
035 |a (OCoLC)1341233712 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Paulmichl, Achim  |e VerfasserIn  |0 (DE-588)1190658267  |0 (DE-627)1669213587  |4 aut 
245 1 0 |a Targeting gastrointestinal stromal tumor with 68Ga-labeled peptides  |b an in vitro study on gastrointestinal stromal tumor-cell lines  |c Achim Paulmichl, Dominik Summer, Claudia Manzl, Christine Rangger, Francesca Orlandi, Sabrina Niedermoser, Takahiro Taguchi, Björn Wängler, Clemens Decristoforo 
264 1 |c 1 Oct 2016 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 16.07.2019 
520 |a The gastrointestinal stromal tumor (GIST) is a rare disease with limited therapeutic options when resistance to tyrosine kinase inhibitor (TKI) treatment occurs. The authors investigated binding of various 68Ga-labeled peptides, targeting receptors reported to be overexpressed in GIST, in different cell lines. For this purpose, three GIST cell lines were tested: GIST-T1, GIST882 (Imatinib sensitive), and GIST430 (Imatinib resistant). DOTA-NT 8-13 (targeting NTR1), DOTA-TATE (targeting SSTR2), CP04 (a minigastrin derivative targeting CCK2-R), VIP-DOTA (targeting VPAC2-R), and 2 DOTA-bombesin derivatives [targeting gastrin releasing peptide receptors (GRPR)] were radiolabeled with 68Ga and incubated with the respective tumor cell and control cell lines. Membrane-bound and internalized activity was measured. Very low or no specific binding to GIST cells was found for all 68Ga-labeled DOTA peptides except for bombesin derivatives indicating no or very low expression of respective receptors. Related to GRPR a pronounced specific binding to all GIST cell lines with no preference related to TKI resistance status was found, both for an agonist (AMBA) with high internalization and for an antagonist (NeoBOMB1) with mainly membrane-bound activity (with up to >80% bound/mg protein). GRPR expression was confirmed by immunohistochemistry. The results show that radiolabeled bombesin analogues, especially antagonists are very promising candidates for targeting GIST. 
700 1 |a Wängler, Björn  |d 1975-  |e VerfasserIn  |0 (DE-588)129702218  |0 (DE-627)477593909  |0 (DE-576)297793888  |4 aut 
773 0 8 |i Enthalten in  |t Cancer biotherapy and radiopharmaceuticals  |d Larchmont, NY : Liebert, 1996  |g 31(2016), 8, Seite 302-310  |h Online-Ressource  |w (DE-627)324660154  |w (DE-600)2029859-6  |w (DE-576)255072864  |x 1557-8852  |7 nnas  |a Targeting gastrointestinal stromal tumor with 68Ga-labeled peptides an in vitro study on gastrointestinal stromal tumor-cell lines 
773 1 8 |g volume:31  |g year:2016  |g number:8  |g pages:302-310  |g extent:9  |a Targeting gastrointestinal stromal tumor with 68Ga-labeled peptides an in vitro study on gastrointestinal stromal tumor-cell lines 
856 4 0 |u https://doi.org/10.1089/cbr.2016.2092  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.liebertpub.com/doi/10.1089/cbr.2016.2092  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190716 
993 |a Article 
994 |a 2016 
998 |g 129702218  |a Wängler, Björn  |m 129702218:Wängler, Björn  |d 60000  |d 62900  |e 60000PW129702218  |e 62900PW129702218  |k 0/60000/  |k 1/60000/62900/  |p 8 
999 |a KXP-PPN1669214087  |e 3493569645 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"Targeting gastrointestinal stromal tumor with 68Ga-labeled peptides","subtitle":"an in vitro study on gastrointestinal stromal tumor-cell lines","title_sort":"Targeting gastrointestinal stromal tumor with 68Ga-labeled peptides"}],"language":["eng"],"person":[{"display":"Paulmichl, Achim","given":"Achim","role":"aut","family":"Paulmichl"},{"display":"Wängler, Björn","given":"Björn","role":"aut","family":"Wängler"}],"name":{"displayForm":["Achim Paulmichl, Dominik Summer, Claudia Manzl, Christine Rangger, Francesca Orlandi, Sabrina Niedermoser, Takahiro Taguchi, Björn Wängler, Clemens Decristoforo"]},"physDesc":[{"extent":"9 S."}],"id":{"eki":["1669214087"],"doi":["10.1089/cbr.2016.2092"]},"relHost":[{"title":[{"title_sort":"Cancer biotherapy and radiopharmaceuticals","title":"Cancer biotherapy and radiopharmaceuticals"}],"language":["eng"],"part":{"extent":"9","pages":"302-310","issue":"8","text":"31(2016), 8, Seite 302-310","year":"2016","volume":"31"},"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"1996","dateIssuedDisp":"1996-","publisher":"Liebert","publisherPlace":"Larchmont, NY"}],"recId":"324660154","pubHistory":["11.1996 -"],"id":{"eki":["324660154"],"zdb":["2029859-6"],"issn":["1557-8852"]},"disp":"Targeting gastrointestinal stromal tumor with 68Ga-labeled peptides an in vitro study on gastrointestinal stromal tumor-cell linesCancer biotherapy and radiopharmaceuticals","physDesc":[{"extent":"Online-Ressource"}]}],"note":["Gesehen am 16.07.2019"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"1 Oct 2016"}],"recId":"1669214087"} 
SRT |a PAULMICHLATARGETINGG1201